Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Cowen Group
0
Cowen Group
Suggest edits
Overview
News
Investments
8
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Orchard Therapeutics Stock (ORTX): $9 Price Target From Cantor Fitzgerald
Pulse 2.0
Kezar Life Sciences (KZR) Stock: Why The Price Surged Today
$25,000,000
Venture capital (Series B)
CoinDesk
Cowen to Offer Crypto Custody Services Through $25M Stake in PolySign
Xconomy
Bristol Myers to Buy MyoKardia, FDA-Ready Heart Disease Drug for $13.1B
Xconomy
Perceptive Advisors’ LianBio Inks Deals With BridgeBio, MyoKardia
$10,000,000
Venture capital (Series A)
neurons.AI
Kyber Data Science Bags $10M in Series A Round of Financing
Forbes Tech
Teladoc To Buy Livongo Health In $18.5 Billion Virtual Care Mega-Deal
FinSMEs
,
neurons.AI
Kyber Data Science Raises $10M in Series A Financing
neurons.AI
Kyber Data Science Raises $10 Million In Series A
neurons.AI
Kyber Data Science Announces $10 Million Series A Financing Round
neurons.AI
Kyber Data Science Announces $10 Million Series A Financing Round
Pulse 2.0
Livongo Health Stock (LVGO): Should I Buy It Now?
Xconomy
MyoKardia’s Heart Drug Shines in Phase 3, FDA Filing Planned for 2021
the home of AI info
Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...
the home of AI info
Minerva Neurosciences Inc. (NERV)'s Financial Results Comparing With MyoKardia Inc. (NASDAQ ...
oliverwyman
Q&A: Livongo on Breaking into a New Digital Health Market
MedCity News
Livongo playing a critical role in helping employers disrupt healthcare
Xconomy
MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal
FinSMEs
Orchard Therapeutics Prices Initial Public Offering
Stock markets
Health
Costs
$200,000,000
IPO
PE HUB
,
FinSMEs
VC-backed Orchard Therapeutics goes public
Stock markets
